REGENXBIO – Public Company Spotlight at Ophthalmology Innovation Summit @ AAO 2019
Ken Mills, CEO speaks for REGENXBIO during the Public Company Spotlight at OIS@AAO 2019. REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv.
Ken Mills, CEO speaks for REGENXBIO during the Public Company Spotlight at OIS@AAO 2019. REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv.